Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Industry Trends
  • Published:

Progress against AIDS

Nature Biotechnology volume 18, pages 466–467 (2000)Cite this article

There is significant progress in the development of drugs against AIDS and AIDS-related conditions, with more than 100 new medicines currently being tested in various clinical trials. These medicines promise to enhance the pipeline of more than 60 drugs already in use against the disease. Despite the progress, however, it is important to remind ourselves just how staggering this disease is in terms of its socioeconomic impact.

Each day, about 16,000 people worldwide are infected with the virus, with 95% of new cases occurring in developing countries (mostly Africa). More than 2.6 million people died of AIDS in 1999 alone1—the highest reported toll since data gathering about the disease began in the early 1980s. With numbers such as these, AIDS has attracted vast resources from governments, universities, and industry the world over for the single purpose of controlling, preventing, and ultimately curing the disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. HIV/AIDS Information Center (J.A.M.A.). http://www.ama-assn.org/special/hiv/hivhome.htm Henry, K. Ann. Intern. Med. 132, 306–311 (2000).

    Article  CAS  Google Scholar 

  2. Al-Harthi, L. & Landay, A. Basic science. http://www.ama-assn.org/special/hiv/newsline/conferen/retro00/retro00.htm

Download references

Author information

Authors and Affiliations

  1. managing director of RheoGene, 706 Forest Street, Charlottesville, 22903, VA

    Aris Persidis

Authors
  1. Aris Persidis
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Persidis, A. Progress against AIDS. Nat Biotechnol 18, 466–467 (2000). https://doi.org/10.1038/74566

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/74566

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing